Annual Total Assets
$1.20 B
-$386.11 M-24.30%
31 December 2022
Summary:
Mirati Therapeutics annual total assets is currently $1.20 billion, with the most recent change of -$386.11 million (-24.30%) on 31 December 2022. During the last 3 years, it has fallen by -$386.11 million (-24.30%).MRTX Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$1.13 B
+$214.66 M+23.46%
30 September 2023
Summary:
Mirati Therapeutics quarterly total assets is currently $1.13 billion, with the most recent change of +$214.66 million (+23.46%) on 30 September 2023.MRTX Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRTX Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -24.3% | -28.9% |
| 5 y5 years | +178.3% | +161.4% |
MRTX Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -24.3% | -28.9% |
Mirati Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $1.13 B(+23.5%) |
| June 2023 | - | $915.04 M(-11.5%) |
| Mar 2023 | - | $1.03 B(-14.0%) |
| Dec 2022 | $1.20 B(-24.3%) | $1.20 B(-7.7%) |
| Sept 2022 | - | $1.30 B(+1.8%) |
| June 2022 | - | $1.28 B(-10.0%) |
| Mar 2022 | - | $1.42 B(-10.5%) |
| Dec 2021 | $1.59 B(+7.6%) | $1.59 B(+26.8%) |
| Sept 2021 | - | $1.25 B(-7.5%) |
| June 2021 | - | $1.36 B(-1.8%) |
| Mar 2021 | - | $1.38 B(-6.5%) |
| Dec 2020 | $1.48 B(+241.5%) | $1.48 B(+138.1%) |
| Sept 2020 | - | $619.85 M(-6.6%) |
| June 2020 | - | $663.95 M(-6.9%) |
| Mar 2020 | - | $713.45 M(+65.1%) |
| Dec 2019 | $432.20 M(+89.2%) | $432.20 M(-8.2%) |
| Sept 2019 | - | $470.70 M(-6.1%) |
| June 2019 | - | $501.46 M(+62.1%) |
| Mar 2019 | - | $309.36 M(+35.4%) |
| Dec 2018 | $228.45 M(+45.3%) | $228.45 M(-7.8%) |
| Sept 2018 | - | $247.69 M(-6.6%) |
| June 2018 | - | $265.19 M(+71.6%) |
| Mar 2018 | - | $154.54 M(-1.7%) |
| Dec 2017 | $157.25 M(+147.9%) | $157.25 M(+91.6%) |
| Sept 2017 | - | $82.06 M(-13.6%) |
| June 2017 | - | $94.98 M(-14.2%) |
| Mar 2017 | - | $110.77 M(+74.6%) |
| Dec 2016 | $63.44 M(-50.4%) | $63.44 M(-19.9%) |
| Sept 2016 | - | $79.16 M(-17.5%) |
| June 2016 | - | $95.99 M(-14.7%) |
| Mar 2016 | - | $112.50 M(-12.1%) |
| Dec 2015 | $128.02 M(+282.4%) | $128.02 M(-10.9%) |
| Sept 2015 | - | $143.68 M(+132.2%) |
| June 2015 | - | $61.87 M(-14.3%) |
| Mar 2015 | - | $72.18 M(+115.6%) |
| Dec 2014 | $33.48 M | $33.48 M(-19.0%) |
| Sept 2014 | - | $41.31 M(-16.8%) |
| June 2014 | - | $49.66 M(-11.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $56.31 M(-12.7%) |
| Dec 2013 | $64.54 M(+62.1%) | $64.54 M(+258.5%) |
| Sept 2013 | - | $18.00 M(-21.9%) |
| June 2013 | - | $23.04 M(-28.3%) |
| Mar 2013 | - | $32.12 M(-19.3%) |
| Dec 2012 | $39.80 M(+28.6%) | $39.80 M(+95.3%) |
| Sept 2012 | - | $20.38 M(-13.1%) |
| June 2012 | - | $23.44 M(-15.2%) |
| Mar 2012 | - | $27.65 M(-10.7%) |
| Dec 2011 | $30.96 M(+183.8%) | $30.96 M(-7.8%) |
| Sept 2011 | - | $33.58 M(-15.0%) |
| June 2011 | - | $39.50 M(+330.2%) |
| Mar 2011 | - | $9.18 M(-15.8%) |
| Dec 2010 | $10.91 M(-48.1%) | $10.91 M(-21.5%) |
| Sept 2010 | - | $13.89 M(-23.1%) |
| June 2010 | - | $18.07 M(+15.9%) |
| Mar 2010 | - | $15.59 M(-25.8%) |
| Dec 2009 | $21.01 M(-47.1%) | $21.01 M(-11.0%) |
| Sept 2009 | - | $23.61 M(-17.6%) |
| June 2009 | - | $28.66 M(-12.6%) |
| Mar 2009 | - | $32.78 M(-17.5%) |
| Dec 2008 | $39.71 M(-46.2%) | $39.71 M(-22.1%) |
| Sept 2008 | - | $51.01 M(-14.1%) |
| June 2008 | - | $59.37 M(-10.6%) |
| Mar 2008 | - | $66.44 M(-10.0%) |
| Dec 2007 | $73.86 M(+12.3%) | $73.86 M(-6.0%) |
| Sept 2007 | - | $78.56 M(+0.7%) |
| June 2007 | - | $77.98 M(+0.1%) |
| Mar 2007 | - | $77.94 M(+18.5%) |
| Dec 2006 | $65.77 M(+118.4%) | $65.77 M(-6.5%) |
| Sept 2006 | - | $70.37 M(+3.3%) |
| June 2006 | - | $68.12 M(+36.6%) |
| Mar 2006 | - | $49.89 M(+65.6%) |
| Dec 2005 | $30.12 M(-26.9%) | $30.12 M(-10.7%) |
| Sept 2005 | - | $33.72 M(-3.6%) |
| June 2005 | - | $34.99 M(-8.9%) |
| Mar 2005 | - | $38.41 M |
| Dec 2004 | $41.18 M(+25.9%) | - |
| Dec 2003 | $32.70 M | - |
FAQ
- What is Mirati Therapeutics annual total assets?
- What is the all time high annual total assets for Mirati Therapeutics?
- What is Mirati Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Mirati Therapeutics?
What is Mirati Therapeutics annual total assets?
The current annual total assets of MRTX is $1.20 B
What is the all time high annual total assets for Mirati Therapeutics?
Mirati Therapeutics all-time high annual total assets is $1.59 B
What is Mirati Therapeutics quarterly total assets?
The current quarterly total assets of MRTX is $1.13 B
What is the all time high quarterly total assets for Mirati Therapeutics?
Mirati Therapeutics all-time high quarterly total assets is $1.59 B